UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 23.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 692,143 shares of the healthcare conglomerate’s stock after selling 207,856 shares during the period. UnitedHealth Group accounts for approximately 2.1% of Robeco Institutional Asset Management B.V.’s investment portfolio, making the stock its 5th biggest position. Robeco Institutional Asset Management B.V. owned approximately 0.07% of UnitedHealth Group worth $364,393,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Texas Capital Bancshares Inc TX raised its position in shares of UnitedHealth Group by 1.1% in the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after buying an additional 19 shares during the last quarter. Tealwood Asset Management Inc. boosted its stake in UnitedHealth Group by 0.4% during the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock worth $2,626,000 after buying an additional 19 shares during the last quarter. Atlas Private Wealth Advisors increased its stake in shares of UnitedHealth Group by 1.1% in the 4th quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock worth $923,000 after acquiring an additional 19 shares during the last quarter. Prentice Wealth Management LLC boosted its position in shares of UnitedHealth Group by 0.8% during the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock valued at $1,235,000 after acquiring an additional 19 shares during the last quarter. Finally, Baker Avenue Asset Management LP raised its stake in UnitedHealth Group by 1.7% during the third quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock worth $615,000 after purchasing an additional 20 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Monday, May 13th. HSBC raised UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 price objective for the company in a research report on Thursday, April 4th. Bank of America reaffirmed a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a report on Wednesday, March 13th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Three equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $570.05.

Check Out Our Latest Analysis on UNH

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Trading Up 0.6 %

Shares of UnitedHealth Group stock traded up $3.36 during trading hours on Friday, reaching $524.63. The stock had a trading volume of 2,657,396 shares, compared to its average volume of 3,305,639. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The firm has a market capitalization of $482.86 billion, a price-to-earnings ratio of 32.07, a P/E/G ratio of 1.52 and a beta of 0.55. The firm has a 50 day simple moving average of $486.41 and a two-hundred day simple moving average of $511.31.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s quarterly revenue was up 8.6% on a year-over-year basis. During the same quarter last year, the firm posted $6.26 earnings per share. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a yield of 1.43%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.